Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Nanorepro AG buy Amped

Start price
€3.38
26.11.20 / 0%
Target price
-
16.11.21
Performance (%)
198.22%
End price
€10.08
17.11.21
Summary
This prediction ended on 17.11.21 with a price of €10.08. With a performance of 198.22% the BUY prediction by Amped was a big success.
Performance without dividends (%)
Name 1w 1m 1y 3y
Nanorepro AG 6.725% 6.725% -19.248% -81.750%
iShares Core DAX® 2.594% -1.861% 13.242% 16.867%
iShares Nasdaq 100 3.553% -2.064% 38.293% 45.898%
iShares Nikkei 225® 0.687% -8.704% 17.510% 2.760%
iShares S&P 500 2.209% -1.988% 27.632% 42.955%

According to Amped what are the pros and cons of Nanorepro AG for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Normal challenges to pay loans and raise capital
Future proof or reliable business model
Differentiated customer and product portfolio
Innovative
Cons
Lower EBIT Margin than peer group
Little known brand
Below average Marketposition
high free float

Comments by Amped for this prediction

In the thread Nanorepro AG diskutieren
Prediction Buy
Perf. (%) 198.22%
Target price
Change
Ends at 16.11.21

Buy Nanorepro AG

In the thread Trading Nanorepro AG
Prediction Sell
Perf. (%) 198.22%
Target price
Change
Ends at 16.11.21

Die von Amped gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Amped for Nanorepro AG

Nanorepro AG

Start price
Target price
Perf. (%)
€3.36
16.11.20
-
16.11.21
0.60%
26.11.20

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€2.94
11.11.20
-
11.11.21
14.29%
16.11.20

Could be worthwhile Investment >10% per year
Standard Investments for future growth
Revenue growth >5% per year expected
Lower EBIT Margin than peer group